1. Mines of cytokine: A treasure trove in pulpal and periapical diseases
   Neelam D Chandwani et al, 2024, Journal of Conservative Dentistry and Endodontics CrossRef
2. The RANK–RANKL axis: an opportunity for drug repurposing in cancer?
   S. Peters et al, 2019, Clinical and Translational Oncology CrossRef
3. RANK/RANKL axis promotes migration, invasion, and metastasis of osteosarcoma via activating NF-κB pathway
   Tomoya Takeda et al, 2024, Experimental Cell Research CrossRef
4. Development of a prognostic gene signature based on an immunogenomic infiltration analysis of osteosarcoma
   Yiyang Yu et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
5. Advances in Osteosarcoma
   Isidora Panez-Toro et al, 2023, Current Osteoporosis Reports CrossRef
6. The OSR9 Regimen: A New Augmentation Strategy for Osteosarcoma Treatment Using Nine Older Drugs from General Medicine to Inhibit Growth Drive
   Richard E. Kast, 2023, International Journal of Molecular Sciences CrossRef
7. OncoTherad® is an immunomodulator of biological response that downregulate RANK/RANKL signaling pathway and PD-1/PD-L1 immune checkpoint in non-muscle invasive bladder cancer
   Ianny Brum Reis et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
8. Low Serum Levels of Soluble Receptor Activator of Nuclear Factor κ B Ligand (sRANKL) Are Associated with Metabolic Dysregulation and Predict Long-Term Mortality in Critically Ill Patients
   Tobias Puengel et al, 2021, Diagnostics CrossRef
9. RANK–RANKL signalling in cancer
   Nathalie Renema et al, 2016, Bioscience Reports CrossRef
10. Drugs in early clinical development for the treatment of osteosarcoma
    Marie-Françoise Heymann et al, 2016, Expert Opinion on Investigational Drugs CrossRef
11. Origin and Therapies of Osteosarcoma
    Brice Moukengue et al, 2022, Cancers CrossRef
12. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin increases the activation of aryl hydrocarbon receptor and is associated with the aggressiveness of osteosarcoma MG-63 osteoblast-like cells
    Shih-Chieh Yang et al, 2018, Oncology Letters CrossRef
13. The Intrinsic and Extrinsic Implications of RANKL/RANK Signaling in Osteosarcoma: From Tumor Initiation to Lung Metastases
    Benjamin Navet et al, 2018, Cancers CrossRef